Wei Chen

pharmacy

H指数:17

被引数:1,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of LEARNS Model-Based Health Education on Swallowing Safety and Psychological Well-Being in Postoperative Esophageal Cancer Patients

基于LEARNS模型的健康教育对术后食管癌患者吞咽安全及心理状况的影响

Journal of Multidisciplinary Healthcare

IF2.4

2026-04-150

OAAI

Nurse-Led Evidence-Based Practice to Promote Gastrointestinal Function Recovery in Women After Cesarean Delivery

护士主导的循证实践以促进剖宫产术后女性胃肠道功能恢复

International Journal of Women's Health

IF0

2025-11-120

OAAI

Postmarketing safety surveillance of 177Lu-DOTA-TATE (LUTATHERA): an observational, pharmacovigilance study leveraging FAERS database

177Lu-DOTA-TATE（LUTATHERA）的上市后安全性监测：一项利用FAERS数据库进行的观察性药物警戒研究

NUCLEAR MEDICINE COMMUNICATIONS

IF1.3

2025-10-010

PRE

Bacteriophages combined with hybridized nanoflower-based electrochemical biosensor for the specific and rapid detection of live Acinetobacter baumannii in real samples

噬菌体与杂交纳米花基电化学生物传感器结合，用于对实际样本中活的鲍曼不动杆菌进行特异且快速的检测。

Microchimica Acta

IF5.3

2025-09-300

PRE

Self-Assembled Immobilization and Metal-Polyphenol Network Encapsulation of β-Galactosidase on T4 Phage for Enhanced Biocatalytic Performance

自组装固定化和金属-多酚网络封装T4噬菌体上的β-半乳糖苷酶以增强生物催化性能

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2025-05-140

PRE

Musculoskeletal adverse events associated with CDK4/6 inhibitors: a real-world study using FDA Adverse Event Reporting System (FAERS) database

与CDK4/6抑制剂相关的肌肉骨骼不良事件：一项基于FDA不良事件报告系统（FAERS）数据库的真实世界研究

toxicology and applied pharmacology

IF2.7

2025-01-290

A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)

HELIYON

IF3.6

2024-09-011

OAAI

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-02-0617

OAAI

Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system

EXPERT OPINION ON DRUG SAFETY

IF3.1

2023-06-134

PRE

Exploring the Far Side of Glycosyl Sulfoxide Activation Process

探索糖基亚砜活化过程的远端

CHINESE JOURNAL OF CHEMISTRY

IF5.5

2022-12-255

PRE

Self-assembled β-galactosidase on T4 phage capsid through affinity binding with enhanced activity and stability for rapid bacteria detection

SENSORS AND ACTUATORS B-CHEMICAL

IF7.7

2022-05-017

PRE

Crystal structure-guided design of berberine-based novel chitinase inhibitors

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2020-11-0916

OAAI

Design and Optimization of Thioglycosyl-naphthalimides as Efficient Inhibitors Against Human O-GlcNAcase

FRONTIERS IN CHEMISTRY

IF4.2

2019-07-253

OAAI

Glycosyl Sulfoxides in Glycosylation Reactions

糖基化反应中的糖基亚砜

TOPICS IN CURRENT CHEMISTRY

IF8.8

2018-06-1233

PREAI

Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2018-02-0217

OAAI

Rh(II) Catalyzed High Order Cycloadditions of 8-Azaheptafulvenes with N-Sulfonyl 1,2,3-TriazIoes or α-Oxo Diazocompounds

ORGANIC LETTERS

IF5

2017-01-0345

PREAI

Nonylphenol induced apoptosis and autophagy involving the Akt/mTOR pathway in prepubertal Sprague-Dawley male rats in vivo and in vitro

TOXICOLOGY

IF4.6

2016-12-0160

PREAI

Synthesis of Eight Stereoisomers of Pochonicine: Nanomolar Inhibition of β-N-Acetylhexosaminidases

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2013-09-3048

PREAI

Design, Synthesis and Biological Evaluation of Cinnamic Acyl Shikonin Derivatives

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2012-11-2631

PREAI

A Highly Efficient Tandem Reaction of 2-(gem-Dibromovinyl)phenols(thiophenols) with Organosilanes to 2-Arylbenzofurans (thiophenes)

2-(gem-二溴乙烯基) 酚 (苯硫酚) 与有机硅烷到2-芳基苯并呋喃 (噻吩) 的高效串联反应

ADVANCED SYNTHESIS & CATALYSIS

IF4

2012-05-0338

PREAI

Wei Chen

个人简介

教育背景

工作经历

荣誉奖项

研究方向